2019 ESC guidelines on diabetes, pre-diabetes and CVD
Video navigation menu
- Reclassification of CV risk in diabetes 02:30
- Recommendations for newer glucose-lowering agents 05:19
- Treatment algorithm for T2DM patients 11:45
- Update of ADA/EASD consensus report 14:33
This lecture by prof. Cosentino was part of a CME accredited symposium "Reducing CV risk in diabetes: the next preventive challenge".
Prof. Cosentino is professor in Cardiovascular Medicine at the department of Cardiology at the Karolinska Institutet in Stockholm, Sweden.
This recording was independently developed under auspices of EPCCS. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of EPCCS.
Funding for this educational program was provided by an unrestricted educational grant from Novo Nordisk A/S.
Watch the presentation of prof. Khunti Watch the presentation of prof. Hobbs
The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.
Share this page with your colleagues and friends: